logo
Kalyanaraman becomes latest to leave Maryland Department of Health

Kalyanaraman becomes latest to leave Maryland Department of Health

Yahoo03-06-2025
Dr. Nilesh Kalyanaraman testified in March on nursing home inspections to the House Health and Government Operations Committee. (Photo by Danielle J. Brown/Maryland Matters)
The deputy secretary of public health services is leaving the Maryland Department of Health this week after two years serving under the Moore Administration and more than a decade in both private and public health services in Maryland, state officials confirmed Monday.
Tuesday will be Dr. Nilesh Kalyanaraman's last day with the department.
'We thank Dr. Kalyanaraman for raising his hand to serve the people of Maryland — especially through the COVID pandemic — as a dedicated champion for public health,' according to a spokesperson for Gov. Wes Moore.
His departure is the latest in a string that began in February, when then-Secretary Laura Herrera Scott left amid several controversies at the department, including oversight issues at Clifton T. Perkins Hospital Center, a high-security hospital that has been riddled with complaints of patient abuse and violence.
Secretary Meena Seshamani, a former top official with the U.S. Centers for Medicare and Medicaid Services, took the reins of the department in April.
Just last week, Erin McCullen left her position as the department's chief of staff, a position she's held since 2023. McCullen also worked in the department in various positions from 2013 through 2017. Chase Cook also left his job last week as the department's director of communications, following several years in the position.
Former CMS administrator takes helm of controversy-laden health department
As the deputy secretary of public health services, Kalyanaraman has spoken on a wide variety of health and safety issues throughout the years — from heat illnesses and dental health workforce to bird flu threat levels and more.
Before working with the Moore administration, Kalyanaraman served as the health officer for Anne Arundel County from September 2019 through March 2023, leading the county through the COVID-19 pandemic.
'He was a really, really good resource for the issues that we dealt with during COVID,' said Sen. Pam Beidle (D-Anne Arundel), chair of the Senate Finance Committee. 'He was always willing to do a webinar with us and our constituents. I think he did a really good job guiding our county through COVID.'
Before his time in local government, Kalyanaraman served from 2012 to 2019 as the chief health officer for Baltimore-based Health Care for the Homeless, a nonprofit that provides health care and housing support to 10,000 people in the region annually.
He leaves a health department that's trying to pull itself out of a series of controversies and challenges. During the 2025 legislative session, lawmakers grilled Kalyanaraman for answers about one of those controversies — a significant backlog of nursing home annual inspections.
Kalyanaraman argued that the department had been making progress on the backlog of state inspections, but lawmakers remain concerned that some facilities had not received annual inspections for over four years, putting vulnerable senior citizens at risk of inadequate care.
Kalyanaraman declined Monday to comment on his departure.
Neither McCullen nor Cook responded to a request for comment. But McCullen said in a social media post about her departure from the health department that she was 'filled with immense gratitude for the privilege of serving alongside such dedicated public servants.'
'The experience has been invaluable, and I am forever thankful for the opportunity to contribute to the health and well-being of Marylanders alongside some of the best people you will ever meet,' she said.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How did John MacArthur die? What we know about pastor's cause of death
How did John MacArthur die? What we know about pastor's cause of death

Yahoo

time34 minutes ago

  • Yahoo

How did John MacArthur die? What we know about pastor's cause of death

John MacArthur, the longtime pastor of a megachurch in Southern California and founder of a syndicated media ministry, died July 14 after being hospitalized with pneumonia. "Our hearts are heavy, yet rejoicing, as we share the news that our beloved pastor and teacher John MacArthur has entered into the presence of the Savior," MacArthur's media ministry, Grace to You, wrote on social media. "This evening, his faith became sight." MacArthur, 86, was the pastor at Grace Community Church, a nondenominational congregation in Sun Valley, California, a post he held since 1969. Tom Patton, another pastor at Grace Community Church, said at a July 13 service that MacArthur had been hospitalized after contracting pneumonia. USA TODAY has reached out to Grace Community Church. MacArthur's cause of death has not been announced, though he had been hospitalized with pneumonia in his final days, Patton said. "This week pastor John contracted pneumonia," Patton said. "He was admitted into the hospital and may be in the presence of the Lord soon." A message on Grace Community Church's website noted the same about MacArthur's condition. "Last week, Pastor John unexpectedly contracted pneumonia, and the Lord took him home on Monday, July 14," the message said. A message on Grace to You's website said MacArthur died "after dealing with some significant health challenges dating back to early 2023." "Just as the details of John's death are new to you, they are new to us as well. We probably have many of the same thoughts and feelings that you do," Grace to You's website said. USA TODAY has reached out to the Los Angeles County Medical Examiner's office for more information. Grace to You's website also said there are currently no details about services for MacArthur. John MacArthur was a pastor and author known for leading Grace Community Church in Sun Valley, California, and for his work with the media ministry Grace to You. He was also the longtime president and chancellor of The Master's University, a private Christian university in Santa Clarita, California, and founder of The Master's Seminary in Los Angeles. MacArthur became the pastor at Grace Community Church in 1969 after graduating from Talbot Theological Seminary in California, according to his leadership bio. Throughout his career, he also wrote nearly 400 books. Like some other preachers across the U.S., MacArthur entered the public spotlight during the COVID-19 pandemic when he hosted large gatherings despite local policies limiting congregations to small numbers outside. "At the center of Dr. MacArthur's ministry was an unwavering commitment to declare God's truth, and Pastor John preached the Word in season and out of season," Grace Community Church's website says. "Even in recent years, though beset with health challenges, he persisted in teaching, leading, and investing in the ministries the Lord had entrusted to him." In addition to his wife of 61 years, Patricia, MacArthur is survived by four children, fifteen grandchildren and nine great-grandchildren. Contributing: James Powel and Natalie Neysa Alund, USA TODAY Melina Khan is a national trending reporter for USA TODAY. She can be reached at This article originally appeared on USA TODAY: How did John MacArthur die? Grace Community Church announces his death

Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Yahoo

time35 minutes ago

  • Yahoo

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia-Pacific pharmaceutical arena this year. Sino already owns a 4.91% stake courtesy of an investment in November 2024, with the company now seeking to purchase the remaining 95.09% it does not own. At the time, Sino spent 142 million yuan ($19.80m) to initiate its ownership involvement with the biotech. The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction. Following the completion of the nearly billion-dollar deal, LaNova Medicines will become an indirect wholly owned subsidiary of Sino. A timeline of 30 business days has been set by the companies to finalise the deal. Sino revealed the acquisition agreement after trading hours on 15 July. The share price in the company had climbed 3.6% by market close. LaNova's drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. Sino stated the acquisition would strengthen its research and development capabilities, subsequently enhancing competitiveness and innovation in the oncology market. LaNova's pipeline has already been raided twice by US big pharma companies. In 2023, AstraZeneca licensed LM-305, a G-protein targeting-ADC, for $600m. A year later, MSD outlaid more than $3bn to secure global rights to LM-299, an anti-PD-1/VEGF bispecific antibody. According to Sino, LaNova Medicines has two projects in the registration clinical stage, six projects in the Phase I/II clinical trial stage, and more than ten projects in the preclinical research stage. In a statement, Sino said: 'Through the in-depth synergy and integration of the advantageous resources of both parties, not only will the potential value of LaNova Medicines be fully released, but also [Sino's] innovation capability will be comprehensively enhanced." The company added that the transaction will help towards its 'strategic goal of advancing towards a world-class innovative pharmaceutical enterprise'. China's economy grew 5.2% year-on-year in Q2, defying the lingering effects of US President Trump's trade war and reinforcing its position as the world's top exporter. This economic resilience is mirrored in China's growing role in the global oncology market. Despite economic pressures, licensing promising drug candidates from Chinese biotechs is becoming a well-trodden path for many US big pharma companies. Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates. For deals specific to US companies, the analysis found that total deal value rose from $15.7bn in 2023 to $21.3bn in 2024. GlobalData is the parent company of Pharmaceutical Technology. "Sino Biopharma spends $951m to acquire China-based LaNova Medicines" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Alpha Aesthetics Partners Expands National Platform With New Esthetics Center Clinic In Fair Oaks, CA
Alpha Aesthetics Partners Expands National Platform With New Esthetics Center Clinic In Fair Oaks, CA

Yahoo

time44 minutes ago

  • Yahoo

Alpha Aesthetics Partners Expands National Platform With New Esthetics Center Clinic In Fair Oaks, CA

FAIR OAKS, Calif., July 15, 2025 /PRNewswire/ -- Alpha Aesthetics Partners—a Thurston Group portfolio company and one of the fastest-growing medical aesthetics platforms in the U.S.—is excited to announce the grand opening of its newest clinic in Fair Oaks, California. This new location, developed in partnership with Esthetics Center, Northern California's leading medical aesthetics brand, represents a key milestone in Alpha's national expansion and de novo growth strategy. Located at 5442 Hazel Avenue, Suite 504 in Fair Oaks, CA, the newly built clinic embodies Alpha's commitment to creating high-performing, brand-authentic med spas focused on operational excellence, superior clinical outcomes, and exceptional patient care. Esthetics Center—led by double-board-certified physician Dr. Reginald Rice—is a recognized leader in luxury medical aesthetics. With established locations in El Dorado Hills, Rocklin, and Sacramento, the new Fair Oaks clinic marks the next chapter of the brand's growth in partnership with Alpha Aesthetics Partners. John Wheeler, CEO of Alpha Aesthetics Partners, shared, "This opening reflects how Alpha builds—with excellence, intentionality, and deep respect for the brand identity that makes each of our partners special. Esthetics Center has set a high bar for patient care and aesthetic results, and we're proud to support their continued expansion into Fair Oaks and beyond." Reginald Rice, MD, FACS, Medical Director of Esthetics Center, stated: "Our expansion into Fair Oaks reflects our continued commitment to safe, effective, and medically advanced aesthetic care. Through our partnership with Alpha, we've been able to scale thoughtfully while maintaining the high clinical standards and personalized approach that define Esthetics Center. This new location allows us to reach more patients while staying true to our mission of delivering exceptional, outcomes-driven care." The Fair Oaks clinic is a key part of Alpha's broader growth strategy to scale through both de novo development and strategic partnerships with top-tier aesthetic practices. Backed by Thurston Group, a Chicago-based private equity firm with a strong track record in healthcare services, Alpha is well-positioned to meet the rising national demand for medical aesthetics. About Alpha Aesthetics Partners:Founded in 2023, Alpha Aesthetics Partners aims to advance the medical aesthetics industry through best-in-class partner support and clinical training. With a vision to build the best operating and largest network of medical aesthetics partners in the world, Alpha focuses on making med spa ownership simpler and more collaborative—allowing partners to focus on delivering world-class patient care. The company currently operates across 27 locations in 11 states. About Esthetics Center:Esthetics Center is one of Northern California's most respected medical aesthetics brands and a founding partner of Alpha Aesthetics Partners. With expert providers, elevated patient care, and a commitment to natural-looking results, the brand has expanded from its flagship location in El Dorado Hills to Rocklin, Sacramento, and now Fair Oaks. As an early leader in Alpha's national network, Esthetics Center continues to set the standard by blending science, artistry, and personalized care. Learn more at About Thurston Group:Thurston Group is a private equity firm that focuses on building industry-leading companies in the healthcare services sector. Founded in 1986 by its Chairman and Founder, Patrick J. Haynes III, Thurston Group has returned over $4 billion of invested capital in its 38-year history. Thurston has an extensive track record of partnering with physicians and building fast-growing businesses, including Smile Doctors, US Endodontics Partners, US Oral Surgery Management, SGA Dental Partners, US Orthopedic Partners, Gen4 Dental Partners, ARC Health, Options Medical Weight Loss, Alpha Aesthetics Partners, and Modis Dental Partners, among others. Media Contact:John WheelerCEOAlpha Aesthetics View original content to download multimedia: SOURCE Alpha Aesthetics Partners Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store